QQQI's 13.8 Percent Monthly Yield Draws Investor Scrutiny
The NEOS QQQI ETF offers a high monthly yield, but hidden costs could erode capital in calmer markets. This report ex...
Which Costs More Index Fund Or Target Date Retirement
This guide compares the cost profiles of Index Fund and Target Date Retirement funds, highlighting where charges differ and how to choose cost-efficient options.
28,430 articles
Buffett Said Would 1,000,000: Is the Dow Realistic?
Warren Buffett's century-spanning Dow forecast remains a talking point as the index sits in the mid-30,000s in 2026. ...
What $9,500 a Month Really Means for a Retired Couple
A retiree couple taking in $9,500 per month sits on the edge of the 12%/22% federal tax brackets, where withdrawal ch...
IShares Semiconductor Soared 112.8%: Half-Year Outlook
The iShares Semiconductor ETF surged in the first half of 2026, powered by AI infrastructure demand and a rebound in ...
Couple’s Home Gained More Than Exclusion, Staying Put Beats Sale
A retired couple confronts a tax cliff as their home equity climbs. They choose to stay, prioritizing a stepped-up ba...
James Beek Gave Heather: Lessons on Wedding Finances 2026
A famous blessing story lights up wedding finances with practical, down-to-earth lessons. Learn how to plan budgets, ...
Which Animal Personality Pairings Work Best for Finances
Money dynamics in relationships vary as widely as people do. This guide uses playful animal personalities to show whi...
What Does Arteris CEO's Stock Sale Mean for Investors
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
Social Security Took $1.45 Trillion Revenue, Yet Short
The latest Social Security Trustees report shows social security took $1.45 in revenue in 2025, but outlays exceeded ...
Is SCHD Better Dividend Than VIG? A Practical Guide
Choosing between SCHD and VIG comes down to your goals: current income vs. steady growth. This guide breaks down how ...
Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
This Life Sciences Supplier Plunges 50% as Fund Buys Stock
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status